A Brucella bacterium is modified by partial or complete deletion of the pgm gene, rendering the bacterium incapable of synthesizing a key enzyme in the metabolism of bacterial sugars. A live vaccine for immunization, prophylaxis or treatment of brucellosis comprises such a bacterium, either lyophilized or in a pharmaceutical vehicle. Nucleotide sequence fragments having the aforementioned deletion are disclosed, with methods for making them.

 
Web www.patentalert.com

< Fungal cell wall synthesis gene

> Process for the manufacture of iohexol

> Substance fki-1033 and process for producing the same

~ 00522